Related references
Note: Only part of the references are listed.Variations in fibrinolytic parameters and inhibin-A in pregnancy: related hypertensive disorders
M. T. SARTORI et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2008)
Screening for trisomy 21 by maternal age, fetal nuchal translucency thickness, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A
K. O. Kagan et al.
ULTRASOUND IN OBSTETRICS & GYNECOLOGY (2008)
Uterine artery Doppler at 11+0 to 13+6 weeks in the prediction of pre-eclampsia
W. Plasencia et al.
ULTRASOUND IN OBSTETRICS & GYNECOLOGY (2007)
Concentrations of plasminogen activators and their inhibitors in blood preconceptionally, during and after pregnancy
Marianne Coolman et al.
EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2006)
Coagulation and fibrinolysis in preeclampsia and neonates
MT Tanjung et al.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS (2005)
An integrated model for the prediction of preeclampsia using maternal factors and uterine artery Doppler velocimetry in unselected low-risk women
CKH Yu et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2005)
Haemostatic changes in pregnancy
KA Bremme
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2003)
Haemostasis in normal and abnormal pregnancy
MN O'Riordan et al.
BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY (2003)
Blood coagulation
LA Norris
BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY (2003)
Levels of plasminogen activators and their inhibitors in maternal and umbilical cord plasma in severe preeclampsia
EM Roes et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2002)
Altered plasma concentrations of leptin, transforming growth factor-β1 and plasminogen activator inhibitor type 2 at 18 weeks of gestation in women destined to develop pre-eclampsia.: Circulating markers of disturbed placentation?
T Clausen et al.
PLACENTA (2002)
Share Paper
